stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / TNDM / Revenue

Tandem Diabetes Care, Inc. Revenue 2012–2025

Tandem Diabetes Care, Inc. (TNDM) annual revenue by fiscal year, computed from SEC filings. Compound growth +58.8%/yr over 13 years.

Fiscal yearRevenueChange (YoY)
FY 2025$1.01B+7.9%
FY 2024$940.20M+25.7%
FY 2023$747.72M-6.7%
FY 2022$801.22M+14.0%
FY 2021$702.80M+40.9%
FY 2020$498.83M+37.7%
FY 2019$362.31M+97.0%
FY 2018$183.87M+70.9%
FY 2017$107.60M+27.7%
FY 2016$84.25M+15.6%
FY 2015$72.85M+46.5%
FY 2014$49.72M+71.4%
FY 2013$29.01M+1072.0%
FY 2012$2.48M

Source: Tandem Diabetes Care, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Tandem Diabetes Care, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Tandem Diabetes Care, Inc. — frequently asked questions

What is Tandem Diabetes Care, Inc.'s revenue?

Tandem Diabetes Care, Inc. (TNDM) reported revenue of $1.01B for fiscal year 2025, per its SEC filings.

How has Tandem Diabetes Care, Inc.'s revenue changed over time?

Between fiscal 2012 and 2025, TNDM's revenue grew at roughly 58.8% per year (compound annual rate), from $2.48M to $1.01B.

Where does this data come from?

Figures are computed from Tandem Diabetes Care, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More TNDM financial history

Full TNDM fundamentals page → · All 1,500+ companies →